RUNWALENTR vs SYMBIOTEC: Stock Comparison

Head-to-head financial and trading comparison between Runwal Enterprises Limited (RUNWALENTR) and Symbiotec Pharmalab Limited (SYMBIOTEC) in the Cross-Sector Peers sector.

RUNWALENTR

NSE: RUNWALENTR
Runwal Enterprises Limited
₹262.55
1Y Return: -12.9%
52W High: ₹301.45
52W Low: ₹262.55
Annual Volatility: 31.31%
Check RUNWALENTR Trade Fees →

SYMBIOTEC

NSE: SYMBIOTEC
Symbiotec Pharmalab Limited
₹1,087.50
1Y Return: -0.93%
52W High: ₹1,198.00
52W Low: ₹1,003.35
Annual Volatility: 53.35%
Check SYMBIOTEC Trade Fees →

Key Metrics Comparison Table

MetricRUNWALENTRSYMBIOTECEdge / Winner
Current Market Price (CMP) ₹262.55 ₹1,087.50 —
1-Year Price Return -12.9% -0.93% SYMBIOTEC (11.97% higher)
52-Week High ₹301.45 ₹1,198.00 —
52-Week Low ₹262.55 ₹1,003.35 —
30-Day Annualized Volatility 31.31% 53.35% RUNWALENTR (Steadier)
30-Day Average Daily Volume 3,362,406 2,798,957 RUNWALENTR (Higher Liquidity)
Statutory Cost to Trade ₹1 Lakh ₹118.50 ₹118.50 Identical statutory tariff

Frequently Asked Questions

Between RUNWALENTR and SYMBIOTEC, which stock gave better returns over the last year?

SYMBIOTEC has outperformed RUNWALENTR over the past 12 months with a gain of -0.93% compared to -12.9%.

Which stock is less volatile: RUNWALENTR or SYMBIOTEC?

RUNWALENTR demonstrated lower price volatility (31.31% annualized) compared to SYMBIOTEC (53.35%). Lower volatility generally indicates steadier price action during market downturns.

What is the statutory cost to buy ₹1,00,000 of RUNWALENTR vs SYMBIOTEC?

Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).

Are RUNWALENTR and SYMBIOTEC direct sector competitors?

Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.